Dragon Pharma S 23 Mastorin 10 mg - Research SARM Tablets

Dragon Pharma S 23 Mastorin 10 mg - Research SARM Tablets

Dragon Pharma S 23 Mastorin 10 mg supplies S-23 as 100 tablets of 10 mg. S-23 is a non-steroidal selective androgen receptor modulator that has been studied as a male contraceptive candidate rather than as a therapeutic product, which is why it carries the reputation of the most suppressive compound in the group. Nothing in the SARM category is an approved medicine. S 23 for sale from a GMP manufacturer with batch testing and a Certificate of Analysis on file.

• S-23 (Mastorin) 10 mg per tablet, 100 tablets per pack
• Research selective androgen receptor modulator, oral
• No half-life established in the sources checked
• GMP-manufactured, HPLC-verified, COA on file per batch

How S 23 Works

S-23 binds the androgen receptor with high potency and has been investigated as a hormonal male contraceptive, which places the emphasis of the research on suppression of spermatogenesis and of natural testosterone rather than on anabolic selectivity. There is no established half-life, so effect timing cannot be modelled the way it can for Ligandrol or Ostarine. Reported effects include lowered libido and changes to erectile function alongside lipid shifts, and liver damage is described as a risk shared across the class. Testolone is the other high-potency entry in the same group.

Research Amounts and Handling

No dose is approved and the compound has no clinical dose to copy, so the only figures available are non-medical practice. Community material describes 10 to 25 mg per day, with runs kept short, and notes that suppression and lipid changes appear early. The 10 mg tablet this page carries is the lower end of that reported range. Because suppression is the defining effect, recovery is planned with Nolvadex or Clomid and bloodwork is treated as routine.

Quality & Authenticity

Every batch is produced under GMP conditions and checked by independent HPLC, with the Certificate of Analysis held for the batch, since an unapproved research compound has no other identity check. Cardarine is listed in the same category but is a PPAR-delta agonist rather than a SARM, and it does not share the suppression profile. Given the potency of S-23 and the absence of pharmacokinetic data, this is the entry on the line to treat with the most caution.

For laboratory research only. Consult a healthcare professional before use.

Consult a healthcare professional before any cycle. Doses are common community protocols.